[The role of Insulin-like Growth Factor 1, Receptor Activator for Nuclear Factor κB ligand - Osteoprotegerin system, Interleukin 6 and 1β in post-transplantation bone metabolic disease in childhood].

CONCLUSIONS: Our data indicates that factors influencing bone remodelling change dynamically in the post-transplantation period.It suggests that serum RANKL and IGF-1 levels could be markers of bone metabolism after HSCT in paediatric patients. PMID: 24002950 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24002950?dopt=Abstract

Source: Endokrynologia Polska - September 7, 2013 Category: Endocrinology Authors: Wędrychowicz A, Sztefko K, Majka M, Ratajczak MZ Tags: Endokrynol Pol Source Type: research